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Abstract
The Kavli HUMAN Project (KHP) will provide groundbreaking insights into how biological, medical, and social factors
interact and impact the risks for cognitive decline from birth through older age. It will richly measure the effect of
cognitive decline on the ability to perform key activities of daily living. In addition, due to its family focus, the KHP will
measure the impact on family members, including the amount of time that family members spend providing care to
older adults with dementia. It will also clarify the division of caregiving duties among family members and the effects
on caregivers’ work, family life, and balance thereof. At the same time, for care that the family cannot provide, it will
clarify the extent to which cognitive decline impacts healthcare utilization and end-of-life decision making.
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Introduction
Dementia is a common and feared aging-related condi-
tion characterized by declines inmemory and other cogni-
tive functions that are severe enough to cause the loss of
independent function and difficulties with activities of
daily living. Dementia has a large and growing impact on
older adults, their families, and government programs in
the United States and around the world. About 4.2 million
adults in the United States, and more than 35 million
worldwide, had dementia in 2010,1 with an estimated eco-
nomic impact in the United States of about $200 billion2
and $600 billion worldwide,3 including a large burden of
unpaid caregiving provided by families. Because of the
sharp increase in the incidence of dementia at older ages
and the expected growth in the worldwide elderly popula-
tion in the decades ahead (from about 600 million in 2015
to 1.5 billion in 2050), the number of dementia cases is
expected to triple by 2050, absent new interventions to
prevent or slow the trajectory of cognitive decline.1,4
Recognition of the growing impact of dementia has
led governments around the world to prioritize
expanding the collection of data on individuals and
populations to understand, address, and track better
the current and future impact of the dementia epidemic.
For instance, the National Alzheimer’s Project Act
(NAPA) was signed into law by President Obama in
2011 in order to expand U.S. government efforts to im-
prove treatment and prevention, and to collect data to
track progress of these efforts in the future. The G8
Dementia Summit was held in London in 2013 in recog-
nition of the growing global impact of Alzheimer’s dis-
ease (AD) and dementia, and to begin to coordinate
efforts for international collaboration and data sharing.
The World Health Organization also recently identified
dementia as a ‘‘public health priority’’ that should be on
all countries’ public health agenda.4
While the large growth in the number of older adults
in the coming decades will lead to an increase around
the world in dementia cases, a number of recent studies
have suggested that the age-specific risk of dementia
has actually decreased in high-income countries over
the last 25 years, possibly due to more aggressive
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treatment of cardiovascular risk factors that increase
the risk of cognitive decline (e.g., diabetes, hyperten-
sion, and high cholesterol), as well as a worldwide
boom in educational attainment, which is thought to
increase the ‘‘cognitive reserve’’ of older adults.5 How-
ever, it is unclear whether the recent large increase in
the prevalence of obesity and diabetes around the
world will cause a slowing or reversal in this optimistic
trend, and it is also unclear whether there has been a
similar or opposite trend in low- and middle-income
countries.6,7
Over the last two decades, the conceptualization of
the cause for cognitive decline and dementia in older
adults has evolved from a focused derangement of a
few biological pathways (e.g., the amyloid cascade
of AD; multiple strokes causing vascular dementia)
toward a fuller life course, multifactorial syndrome
that results in overlapping brain pathologies (‘‘mixed
dementia’’ from amyloid plaques, vascular insults,
and Lewy-body pathology) due to both biological and
social stressors from the womb through old age. In
this way, dementia is a prototypical health condition
that requires a ‘‘life-course’’ perspective because of the
exquisite sensitivity of the development of brain cells
and the healthy wiring of brain networks to both
daily biological and social stressors.8
The intensive longitudinal daily data collection
planned for the Kavli HUMAN Project (KHP) will pro-
vide new opportunities for ground-breaking insights
into how biological, medical, and social factors interact
to increase or decrease the risks for cognitive decline
from birth through older age, including: (a) the trans-
mission of ‘‘brain health’’ across generations (e.g., ma-
ternal health and brain gestation; early parent–child
social interactions and the building of ‘‘cognitive re-
serve’’); (b) how education, cognitive stimulation, and
daily cognitive activity (reading text, smartphones,
the Internet, etc.) are linked with brain health and
the risk for later-life cognitive decline; (c) how key car-
diovascular risk factors, such as hypertension, diabetes,
vascular disease, and physical inactivity, affect the risk
for cognitive decline; and (d) how social life and social
interactions are related to brain health and the risk for
cognitive decline.
In addition to providing new and unique data re-
garding the complex interaction among biological,
medical, and social risk factors for cognitive decline,
the KHP will provide an unprecedented opportunity
to understand better the wide-ranging impact and out-
comes of cognitive decline on individuals, their fami-
lies, and the wider social networks in which they live
their daily lives, including: (a) changes in the ability
to perform key activities of daily living; (b) the amount
of time that family members spend providing daily care
to older adults with dementia, as well as the trajectory
caregiving time as cognitive impairment worsens; (c)
the dynamics of the division of caregiving duties
among family members, and how caregiving affects
the work and family life of caregivers; and (d) health-
care utilization and decision making at the end-of-life.
There are many key measurement opportunities and
challenges involved in developing the ideal data set. A
key set of factors to be measured are maternal activities
during gestation. There are also important early-life in-
teractions and opportunities to be measured. For exam-
ple, more educated parents likely speak with their
children in different ways than less educated parents,
perhaps leading to different levels of ‘‘cognitive reserve’’
and, therefore, different levels of risk for late-life cogni-
tive decline. In regard to measurement, a number of
studies have used in-home recordings of parent–child
conversations to identify the quantity and ‘‘quality’’ of
cognitive stimulation for kids. It is also increasingly pos-
sible to track daily cognitive activity (reading text, smart-
phone use, Internet use, etc.), including how labor force
participation affects risk for cognitive decline in later life.
Another important set of risk factors to measure re-
late to physical activity and biological markers. In addi-
tion to simple measures of how sedentary individuals
are, it is important to track exercise patterns. Going
further, it is important to measure such cardiovascular
risk factors by monitoring blood pressure, related dis-
eases, and the extent to which programs to control
these are implemented (diabetes control, etc.). Other
risk factors to measure include dietary choices, alcohol
use, and use of other substances that are psychoactive
and may contribute either positively or negatively to
cognitive abilities in later life. It is also important to
track mental health directly, including ongoing anxiety,
depression, and more severe conditions, along with the
measures and substances taken in an effort to rectify
such conditions.
Given that the ultimate object of study is cognitive
decline, it is also important to monitor and improve
understanding of possible early warning signals.
These may include changes in financial activities and
patterns of decision making, such as ‘‘giving up the
checkbook.’’ There may be a concomitant pattern of in-
creased risk of being a victim of financial fraud, so that
key financial transactions must be monitored. There
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are also possible telltale patterns of movement, such as
constriction of daily geography (e.g., not venturing far
from familiar places). It is also important to track
changes in the frequency and types of social interac-
tions, as well as changes in speech patterns.
Implementation in the KHP
A key advantage of the holistic approach that KHP lib-
erates is the ability to track the impact of cognitive de-
cline on a large number of outcome variables. In the
medical arena, it is important to track how cognitive
decline is caused by and contributes to general health,
function, and well-being in later life. It is also impor-
tant to monitor the impact of cognitive decline on fam-
ilies and social networks. Of particular interest is the
impact on labor-force participation of individuals and
their caregivers. It is also important to track the eco-
nomic cost of healthcare utilization, long-term care,
and informal caregiving.
To achieve these ambitious targets, the KHP will de-
velop a rich set of methods for measuring and tracking
cognitive function. It is proposed that standard cogni-
tive screening batteries be undertaken at yearly inter-
vals. This will be combined with daily measurement of
aspects of cognitive function with smartphone apps
and other monitoring devices. GPS information will be
used to gauge how daily ‘‘life space’’ changes as cognition
declines. There may also be occasion to conduct explicit
brain images at regular intervals and at key moments of
change. Finally, there may be need for proxy (infor-
mant) assessments of cognitive and other functions as
individuals become less able to participate in survey or
other self-report data collection.
Overall, investigation of factors that contribute to cog-
nitive decline from birth through older age would utilize
the following KHP data sets, amongst others. (a) Medi-
cal information on the mother’s health, pregnancy, and
birth of the baby would be available from the medical
history and records going forward (EMRs, doctors’
notes, hospital records, dental records). Prescription
data would be gathered via the New York State Prescrip-
tion database. This information would be comple-
mented by the SPARCS database and the KHP’s own
tests: blood tests (blood metals, vitamins, lipids, glu-
cose, and other biomarkers) together with urine and
hair tests (smoking, alcohol, and substance use) every
3 years. (b) Exposure to toxins and other chemicals
would be measured via silicone wristbands worn peri-
odically. (c) Formal education data would be available
via participants’ record cards, standardized test results
(e.g., No Child Left Behind, ACT, SAT), and New York
City Department of Education databases on student
progression and school rankings. (d) Information on
informal education would be gathered by KHP field
teams via questionnaires on extracurricular activities
and by counting the number of books in participants’
homes. (e) Time parents spend together with children
would be measured using Bluetooth-based presence
sensors in the home and by smartphone apps that mea-
sure social interactions. (f) Data on caregiving by fam-
ily members would be available via questionnaires,
Bluetooth-based presence sensors in the home, and a
smartphone app that measures social interactions. (g)
Mobility and activity level information would be col-
lected by activity trackers and smartphone apps. (h)
Time spent on digital devices would be measured by
apps on smartphones, tablets, and PCs. (i) Dietary
data would be collected via periodic food diaries, com-
plemented by mining for food purchases in financial
data (credit cards, debit cards, checks). (j) Information
on financial status and participation in government as-
sistance programs (SNAP, Social Security, TENF)
would be available via financial data gathered using a
combination of automated and survey-based method-
ologies. (k) Information on smoking and alcohol use
would be collected on an ongoing basis by mining for
purchases of tobacco products and alcoholic beverages
in financial data, in addition to the triennial tests using
biological samples.
The impact of various factors on cognition and genet-
ics would be analyzed via the following KHP data sets,
amongst others. (a) Cognitive function levels would be
measured via self-administered psychology question-
naires/tests on smartphones and tablets at intake and
periodically thereafter. (b) Information on genetic vari-
ation—individual and family—would be gathered via
whole genome sequencing of blood samples for adults
(saliva for children) performed at study intake. In addi-
tion, data on epigenetics would be gathered via trienni-
ally performed assays. (c) ‘‘Giving up on the checkbook’’
could be measured indirectly via analyzing trends on the
quantity and types of financial transaction individuals
perform over time.
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